drugset / Trial / NCT05291845
Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
RandomizedFactorialOpen-labelTreatment
Summary
To follow up the efficacy and safety of Candida antigen, bivalent HPV vaccine in treatment of common warts either mono or combined intralesional therapy
Timeline
- Start
- 2022-04-03
- Primary completion
- 2025-10-03
- Completion
- 2025-12-06
Publications
- Results Nofal A, Marei A, Ibrahim AM, Nofal E, Nabil M. Intralesional versus intramuscular bivalent human papillomavirus vaccine in the treatment of recalcitrant common warts. J Am Acad Dermatol. 2020 Jan;82(1):94-100. doi: 10.1016/j.jaad.2019.07.070. Epub 2019 Jul 29.
- Results Nassar A, Alakad R, Essam R, Bakr NM, Nofal A. Comparative efficacy of intralesional Candida antigen, intralesional bivalent human papilloma virus vaccine, and cryotherapy in the treatment of common warts. J Am Acad Dermatol. 2022 Aug;87(2):419-421. doi: 10.1016/j.jaad.2021.08.040. Epub 2021 Aug 28. No abstract available.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Candida antigen vaccine | Vaccine | — | Other |
| Subject | Cervarix | Vaccine | — | Other |